Literature DB >> 30371915

Analysis of Macular Vessel Density and Foveal Avascular Zone Using Spectral-Domain Optical Coherence Tomography Angiography in Children With Amblyopia.

Bengi Demirayak, Asli Vural, Ismail Umut Onur, Fatma Selin Kaya, Fadime Ulviye Yigit.   

Abstract

PURPOSE: To quantify the foveal avascular zone and the whole, parafoveal, and foveal vessel density of superficial and deep capillary plexus in amblyopic eyes and age-matched controls and to compare the measurements.
METHODS: This cross-sectional study involved 49 eyes from 17 patients with amblyopia and 21 healthy children (aged 6 to 16 years). Optical coherence tomography angiography was performed for all participants and superficial capillary plexus, deep capillary plexus, and foveal avascular zone were evaluated. Data from amblyopic eyes, fellow eyes with unilateral amblyopia, and control eyes were compared using the Mann-Whitney U test.
RESULTS: The mean patient age was 8.6 ± 2.5 years in the amblyopia group and 9.6 ± 2.9 years in the control group. The mean foveal avascular zone measurements were 0.251 ± 0.1 mm2 in the amblyopia group and 0.291 ± 0.1 mm2 in the control group. The whole, foveal, and parafoveal vessel densities of superficial capillary plexus were 48.8% ± 3.7%, 23.8% ± 8.8%, and 50.9% ± 4.6% in the amblyopia group and 48.4% ± 2.5%, 19.3% ± 5.4%, and 51.3% ± 2.7% in the control group. The whole, foveal, and parafoveal vessel densities of deep capillary plexus were 51.8% ± 4.3%, 37.6% ± 5.8%, and 54.8% ± 4.2% in the amblyopia group and 54.4% ± 3.2%, 34.9% ± 7.4%, and 56.8% ± 3.2% in the control group. No statistically significant difference was detected in all measurements.
CONCLUSIONS: Assessment of the foveal avascular zone and vessel density of superficial capillary plexus and deep capillary plexus with optical coherence tomography angiography revealed no difference between amblyopic eyes, controls, and fellow eyes of patients with unilateral amblyopia. [J Pediatr Ophthalmol Strabismus. 2019;56(1):55-59.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Year:  2018        PMID: 30371915     DOI: 10.3928/01913913-20181003-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  6 in total

Review 1.  Optical coherence tomography angiography-derived flow density: a review of the influencing factors.

Authors:  Viktoria C Brücher; Jens J Storp; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-09       Impact factor: 3.117

2.  Association of Optical Coherence Tomography Angiography Metrics With Detection of Impaired Macular Microvasculature and Decreased Vision in Amblyopic Eyes: The Hong Kong Children Eye Study.

Authors:  Emily S Wong; Xiu-Juan Zhang; Nan Yuan; Jian Li; C P Pang; Lijia Chen; Clement C Tham; Carol Y Cheung; Jason C Yam
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

3.  Inter-Ocular Symmetry of Vascular Density and Retinal Thickness in Unilateral Anisometropic Amblyopia.

Authors:  Zerrin Bayraktar; Seren Pehlivanoglu; Sukru Bayraktar; Sinan Albayrak; Muharrem Karakaya
Journal:  Clin Ophthalmol       Date:  2020-05-07

4.  Effect of amblyopia treatment on macular microvasculature in children with anisometropic amblyopia using optical coherence tomographic angiography.

Authors:  Tengyue Zhang; Shiyong Xie; Yangchen Liu; Caihong Xue; Wei Zhang
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

5.  Optical coherence tomographic angiography in children with anisometropic amblyopia.

Authors:  Chenchen Liu; Yanzhen Zhang; Xiaopeng Gu; Puying Wei; Dehai Zhu
Journal:  BMC Ophthalmol       Date:  2022-06-20       Impact factor: 2.086

6.  Assessment of Foveal Avascular Zone and Macular Vascular Plexus Density in Children With Unilateral Amblyopia: A Systemic Review and Meta-Analysis.

Authors:  Lei Gao; Yang Gao; Fengrong Hong; Peng Zhang; Xiangwen Shu
Journal:  Front Pediatr       Date:  2021-05-21       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.